5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.80▼ | 7.80▼ | 7.81▼ | 7.89▼ | 8.35▼ |
MA10 | 7.86▼ | 7.84▼ | 7.87▼ | 7.91▼ | 7.86▼ |
MA20 | 7.88▼ | 7.94▼ | 7.95▼ | 8.34▼ | 7.23▲ |
MA50 | 7.99▼ | 7.94▼ | 7.99▼ | 7.69▲ | 8.79▼ |
MA100 | 7.95▼ | 8.26▼ | 8.40▼ | 7.34▲ | 14.98▼ |
MA200 | 8.37▼ | 8.17▼ | 7.82▼ | 8.81▼ | 98.75▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.022▼ | -0.032▼ | -0.031▼ | -0.121▼ | 0.273▲ |
RSI | 24.020▼ | 30.280▼ | 33.735▼ | 46.639▼ | 47.838▼ |
STOCH | 22.688 | 23.019 | 13.384▼ | 31.368 | 66.561 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -82.891▼ | -40.246 |
CCI | -350.653▼ | -236.161▼ | -229.641▼ | -74.645 | 35.942 |
CDL | $ATRA Doji Candlestick Pattern Detected | Set Alert |
Thursday, June 26, 2025 02:02 PM
THOUSAND OAKS, Calif., May 17, 2025--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...
|
Monday, May 05, 2025 02:06 PM
THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...
|
Thursday, March 13, 2025 09:00 AM
Atara Biotherapeutics (ATRA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/07/25 | 7.60 | 8.015 | 7.54 | 7.80 | 20,120 |
30/06/25 | 7.93 | 8.07 | 7.60 | 7.72 | 18,849 |
27/06/25 | 7.94 | 8.145 | 7.80 | 7.96 | 22,269 |
26/06/25 | 8.09 | 8.18 | 7.81 | 7.95 | 27,698 |
25/06/25 | 8.25 | 8.25 | 7.76 | 8.02 | 15,434 |
24/06/25 | 8.01 | 8.20 | 7.732 | 8.06 | 29,533 |
23/06/25 | 7.83 | 8.0847 | 7.6825 | 7.88 | 16,739 |
20/06/25 | 8.05 | 8.05 | 7.51 | 7.94 | 86,859 |
18/06/25 | 7.92 | 8.28 | 7.79 | 8.02 | 71,466 |
17/06/25 | 8.38 | 8.38 | 7.74 | 7.80 | 45,473 |
|
|
||||
|
|
||||
|
|